HDEF - ETF AI Analysis
Top Page
Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)
HDEF, the Xtrackers MSCI EAFE High Dividend Yield Equity ETF, earns a solid overall rating thanks to strong, diversified holdings like Novartis, TotalEnergies, Roche, and DBS Group, which combine solid financial performance, attractive dividends, and generally positive business outlooks. However, some holdings such as Allianz and Unilever show bearish or cautious technical signals and valuation concerns, and the fund’s sizable positions in a few large companies and sectors mean investors should be aware of concentration risk in major non-U.S. dividend payers.
HDEF vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.30B
- Region
- Developed Markets
- Expense Ratio
- 0.09%
- Beta
- 0.35
- Issuer
- Xtrackers
- Inception Date
- Aug 12, 2015
- Dividend Yield
- 3.75%
- Asset Class
- Equity
- Index Tracked
- MSCI EAFE High Dividend Yield
HDEF Summary
HDEF is an ETF that follows the MSCI EAFE High Dividend Yield Index, focusing on companies in developed markets outside the U.S. and Canada, such as Europe and Japan. It mainly holds large, established businesses that pay relatively high dividends. Well-known names in the fund include Nestlé and Novartis. Someone might invest in HDEF to get regular income from dividends while also spreading their money across many international companies for diversification. A key risk is that international stock prices and currencies can move up and down, so the value of the ETF can rise or fall over time.
How much will it cost me?
The expense ratio for HDEF is 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because HDEF is passively managed, tracking an index rather than relying on active stock selection.
What would affect this ETF?
HDEF could benefit from stable dividend payouts and growth in developed markets outside North America, especially if sectors like financials and healthcare, which have significant weight in the ETF, perform well. However, challenges such as rising interest rates, economic slowdowns in Europe or Asia, or regulatory changes affecting top holdings like Novartis or Shell could negatively impact returns. Diversification across sectors and regions provides some resilience, but global economic conditions remain a key factor to watch.
HDEF Top 10 Holdings
HDEF leans heavily on a mix of European energy, healthcare, and consumer staples, with a clear tilt toward steady, dividend-rich names outside North America. TotalEnergies and Shell have been rising, giving the fund a strong tailwind from the energy patch, while DBS Group in Singapore adds a solid financial boost. On the flip side, consumer giants Nestlé and Unilever have been lagging, acting like a slight brake on overall returns. Roche and Novartis sit in the middle, offering steady healthcare ballast in this globally diversified, income-focused lineup.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 GB:SHEL | Shell (UK) | 5.91% | $136.77M | GBP 224.21B | 47.13% | 73Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 CH:NOVN | Novartis AG | 4.82% | $111.62M | CHF 228.27B | 19.51% | 80Outperform |
 CH:NESN | Nestlé SA | 4.75% | $109.90M | CHF 212.03B | -0.94% | 71Outperform |
 DE:ALV | Allianz | 4.37% | $101.16M | EUR 164.32B | 19.20% | 67Neutral |
 FR:TTE | TotalEnergies SE | 4.15% | $95.96M | EUR 180.16B | 53.53% | 78Outperform |
 ES:IBE | Iberdrola | 3.56% | $82.44M | EUR 143.04B | 29.03% | 67Neutral |
 GB:ULVR | Unilever | 3.36% | $77.78M | GBP 106.98B | -3.83% | 72Outperform |
 DBSDF | DBS Group Holdings | ― | ― | ― | ― | 78Outperform |
HDEF Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HDEF, the sentiment is Positive. The current price of 33.79 is above the 20-day moving average (MA) of 32.73, above the 50-day MA of 33.31, and above the 200-day MA of 32.16, indicating a bullish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 66.60 is Neutral, neither overbought nor oversold. The STOCH value of 96.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HDEF.
HDEF Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| HDEF | $33.79 | $36.00(6.54% Upside) | $2.30B | 0.09% | 67Neutral |
 IDV | $42.61 | $48.25(13.24% Upside) | $8.26B | 0.50% | 59Neutral |
 DIVI | $42.54 | $49.98(17.49% Upside) | $2.62B | 0.09% | 66Neutral |
 FGD | $33.32 | $36.54(9.65% Upside) | $1.56B | 0.55% | 58Neutral |
 DTH | $55.98 | $61.79(10.37% Upside) | $633.40M | 0.58% | 62Neutral |
 EFAS | $22.07 | $24.63(11.64% Upside) | $60.16M | 0.55% | 56Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HDEF | Xtrackers MSCI EAFE High Dividend Yield Equity ETF | 33.79 | 5.25 | 18.39% | |
| IDV | iShares International Select Dividend ETF | 42.61 | 7.68 | 22.00% | |
| DIVI | Franklin LibertyQ International Equity Hedged ETF | 42.54 | 5.88 | 16.05% | |
| FGD | First Trust Dow Jones Global Select Dividend Index Fund | 33.32 | 5.94 | 21.70% | |
| DTH | WisdomTree International High Dividend Fund | 55.98 | 9.05 | 19.30% | |
| EFAS | Global X MSCI SuperDividend EAFE ETF | 22.07 | 4.42 | 25.04% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.